Inventor · disambiguated record
Stephen E. Ammann
Also filed as: AMMANN STEPHEN · AMMANN STEPHEN E
16 granted patents·11 pending applications·40 citations·filing 2017–2025
90Inventor score
Top patents by PatentIndex Score
27 records- 0196US11702404B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Jul 18, 2023·9 cites·3 claims
- 0292US12121511B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2021·Granted Oct 22, 2024·3 cites·39 claims
- 0392US12091420B2SARS-COV2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Sep 17, 2024·3 cites·28 claims
- 0492US11702414B2Thiadiazole IRAK4 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted Jul 18, 2023·2 cites·4 claims
- 0591US11046686B2Thiadiazole IRAK4 compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jun 29, 2021·5 cites·23 claims
- 0690US12410183B2Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2024·Granted Sep 9, 2025·1 cites·25 claims
- 0790US10875866B2Pyrrolo[1,2-B]pyridazine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·6 cites·6 claims
- 0890US10266503B1Sulfoxide ligand metal catalyzed oxidation of olefinsUNIV ILLINOIS·Filed 2017·Granted Apr 23, 2019·10 cites·14 claims
- 0986US11535622B2Pyrrolo[1,2-b] pyridazine derivativesGILEAD SCIENCES INC·Filed 2020·Granted Dec 27, 2022·1 cites·30 claims
- 1082US12415808B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2022·Granted Sep 16, 2025·0 cites·4 claims
- 1178US12497382B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2023·Granted Dec 16, 2025·0 cites·10 claims
- 1275US2025049780A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1375US2024239807A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1473US12070455B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted Aug 27, 2024·0 cites·29 claims
- 1572US2025099431A1Glp-1r modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1669US11661431B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted May 30, 2023·0 cites·53 claims
- 1769US2023365594A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1865US12060351B2Thiadiazole IRAK4 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Aug 13, 2024·0 cites·7 claims
- 1960US2025042906A1Processes for making irak4 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2058US2024217990A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 2157US2024059673A1Substituted indole compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2257US2025002471A16-substituted indole compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2352US2025034154A1Salts and solid forms of a compound that modulates irak4GILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2447US11572362B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Feb 7, 2023·0 cites·10 claims
- 2547US11053250B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Jul 6, 2021·0 cites·31 claims
- 2647US2025276979A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2745US2025296936A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →